
|Articles|September 1, 2002
Uveitis Update: Medical, surgical options considered for uveitic glaucoma
Editor's Note: Uveitic glaucoma is often not a single disease. Multiple factors, including inflammatory mediators as well as anatomic/morphologic changes, can contribute to the development of elevated IOP. Corticosteroids used to treat the inflammation can also produce elevated IOP. It is important to try to sort out these factors in patients with uveitic glaucoma to determine what category they fit in, and then select the best treatment.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Evolving glaucoma therapy: A new era of interventional strategies
2
Development of maculopathy associated with systemic medications
3
Proactive strategies and sustained delivery advance glaucoma care
4
Throwback Series: When tools of the past teach new lessons
5

















































.png)


